Cherry Tree Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$109K Hold
310
0.02% 203
2025
Q4
$101K Sell
310
-110
-26% -$34.9K 0.02% 220
2025
Q3
$119K Sell
420
-17
-4% -$4.93K 0.03% 205
2025
Q2
$122K Sell
437
-48
-10% -$13.6K 0.03% 197
2025
Q1
$151K Buy
485
+10
+2% +$2.95K 0.04% 176
2024
Q4
$124K Hold
475
0.03% 192
2024
Q3
$153K Hold
475
0.04% 177
2024
Q2
$148K Sell
475
-17
-3% -$4.99K 0.04% 171
2024
Q1
$140K Sell
492
-291
-37% -$85.1K 0.04% 177
2023
Q4
$226K Hold
783
0.06% 144
2023
Q3
$210K Hold
783
0.06% 137
2023
Q2
$174K Buy
+783
New +$182K 0.05% 148

Other funds holding AMGN

Cherry Tree Wealth Management's AMGN Position: Q1 2026 in Review

Cherry Tree Wealth Management held its Amgen (AMGN) position steady in Q1 2026 at 310 shares worth $109K. The position accounts for 0.02% of the portfolio, ranked #203.

Cherry Tree Wealth Management first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $226K in Q4 2023. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cherry Tree Wealth Management held 310 shares of Amgen worth $109K as of Q1 2026.
  • Cherry Tree Wealth Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.02% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #203 holding.
  • Cherry Tree Wealth Management first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Amgen position peaked at $226K in Q4 2023.
  • 3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.